DNA Microarray Market Size, Share & Industry Analysis, By Type (Oligonucleotide DNA Microarrays, Complementary DNA Microarrays), By Application (Gene Expression Analysis, Transcription Factor Binding Analysis, Genotyping, Others), By End-User (Biotechnology & Pharmaceutical Industries, Diagnostic Centers, Hospitals & Clinics, Academic & Research Institutes, Others) and Regional Forecast, 2024-2032

DNA microarray or biochip or gene chip is defined as a collection of microscopic DNA attached to the solid surface, which helps in measuring the expression level of a large number of genes simultaneously. Each DNA spots contain probes which contain small Pico moles of specific DNA sequences. These probe-target hybridizations are usually detected through fluorophore or chemiluminescence labelled to it. DNA microarray can be used to detect DNA or RNA, i.e., cDNA after reverse transcription.

DNA microarray has a wide number of applications in gene expression, proteomics, cancer detection, disease monitoring agriculture sector, and drug discovery, etc. and growing application of DNA microarray in the various sectors is likely to fuel the global DNA microarray market growth during the forecast period. Increase in the advancements in DNA microarray and growing investments in R&D by many key players to develop efficient and accurate DNA microarray are the key factors anticipated to drive the DNA microarray market growth during the forecast period.

Generation of large DNA sequences through automation, effective analysis of gene expression; and growing partnerships among key players are likely to drive the global DNA microarray market growth during the forecast period. For instance, in 2016, Illumina, Inc., signed an agreement with four institutes of genotype i.e., Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute that will genotype different samples in their respective biobanks with the aim to discover genetic factors responsible for cancer, Alzheimer's disease, bipolar disorder, and other complexes disorders. Also rising awareness about advancements in DNA microarray and its growing application in various fields are also anticipated to boost the global DNA microarray market growth during the forecast period.

However, the high cost involved in the sequencing is likely to hinder the DNA microarray market growth during the forecast period.

Key Players Covered

Some of the major companies present in DNA microarray include Illumina, Inc., Thermo Fisher Scientific Inc., Agilent Technology, Arrayit Corporation, Applied Micro Arrays, Messe Düsseldorf GmbH, Savyon Diagnostics, SCIENION AG, WaferGen Biosystems, and others.

Segmentation

Oligonucleotide DNA microarray segment is anticipated to hold the largest share of DNA microarray market during the forecast period as it is a cost-effective tool with huge capability to monitor the expression of every gene in the genome. Additionally, oligonucleotide-based microarrays offer a number of advantages over cDNA microarrays, offering controlled specificity of hybridization, making it more powerful tool for the analysis of single nucleotide polymorphisms, further accelerating the oligonucleotide DNA microarray demand in the forthcoming years.

Key Insights

• Technological Advancements in DNA Microarray Technology


• Regulatory Scenario for Key Countries/Regions


• Key Industry Developments-Partnerships, Mergers and Acquisitions

 Regional Analysis

Geographically, the global DNA microarray market has been segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Asia and Africa. North America is anticipated to dominate the DNA microarray market during the forecast period owing to the presence of key players in the region and growing investments by many key players in the developing technologically advanced DNA microarray products. In Europe, rising awareness about the increase in the application of DNA microarray is likely to drive the DNA microarray market growth during the forecast period. In the Asia Pacific and Latin America, the DNA microarray market is anticipated to grow at a significant rate owing to the growing prevalence of various chronic disorders & cancers and growing adoption of DNA microarray technology. In the Middle East & Africa, growing unmet needs for the diagnosis of the various disease is likely to fuel the DNA market growth during the forecast period.

DNA Microarray Industry Developments

• In September 2018, Novacyt Group collaborated with Applied Microarrays, Inc. with an aim to provide customised microarrays and manufacturing point-of-care (POC) and high throughput DNA and protein arrays, to offer comprehensive single nucleotide polymorphism (SNP) assay development.


• In February 2016, Illumina, Inc., signed an agreement with four institutes of genotype i.e., Vanderbilt University, the University of Colorado at Denver, Partners HealthCare, and the Montreal Heart Institute that will genotype different samples in their respective bio bank with the aim to discover genetic factors responsible cancer, Alzheimer's disease, bipolar disorder, and other complexes disorders